explainer· August 9, 2026
What melanocortin peptides actually are, and why the tanning two don't share a safety record
The peptides that darken skin all pull the same lever, alpha-MSH on the melanocortin-1 receptor. One of them is an FDA-approved drug for a rare disease. Another is a gray-market research chemical with a Skin Cancer Foundation warning attached. Same family, very different files.
For a brand called Tan Girl, the melanocortin peptides are the ones we get asked about most, and the ones we're most careful with. They are the peptides that make skin darker without the sun. That sounds like the whole pitch right there. The honest version is longer, because the two compounds people mean when they say "tanning peptide" sit at opposite ends of the evidence spectrum, and the biology they share doesn't make their safety records the same.
What the pathway is
Your body already has a tanning peptide. It's called alpha-melanocyte-stimulating hormone, or alpha-MSH, and it's cut from a larger precursor protein called POMC. When it lands on a receptor named MC1R, sitting on the surface of your melanocytes, those cells shift toward making eumelanin, the darker, more protective pigment. UV light drives a version of this same signal. That's what a tan is: melanocytes responding to a melanocortin signal by making pigment.
So a synthetic peptide that binds MC1R can, in principle, produce color without the ultraviolet step. The interesting part is that the receptor family has five members, MC1R through MC5R, scattered across skin, brain, gut, and other tissues. How selectively a peptide hits MC1R versus the rest is most of what separates the two compounds below.
The one with a label
, sold as Scenesse, is a 13-amino-acid analog of alpha-MSH that binds predominantly to MC1R. The FDA approved it in October 2019, delivered as a small implant placed under the skin by a clinician. Its approved use is narrow and specific: reducing phototoxic pain in adults with erythropoietic protoporphyria, a rare inherited disorder in which sunlight causes real, burning skin pain. In the trial behind the approval, patients on the drug logged more pain-free hours in direct daylight than patients on placebo.
That is a modest, well-defined result for a small group of people who genuinely suffer in the light. Afamelanotide is not approved, studied, or marketed as a cosmetic tan. It's a drug with a label, a manufacturer, and a monitoring requirement, and the label is for a disease most people have never heard of.
The one without
is the other molecule, and it's a different animal. It's a smaller, cyclic peptide that hits the melanocortin receptors non-selectively, MC1R along with MC3R, MC4R, and MC5R. Reach into the brain-and-gut receptors and you get the side-effect list that shows up in report after report: nausea, facial flushing, appetite changes, spontaneous erections. It is not approved for any use, anywhere, and it's sold as an unregulated research chemical, which means no one is guaranteeing what's actually in the vial.
The cosmetic version does darken skin. The problem is what it darkens along the way. Melanotan II tells every melanocyte to make pigment, including the ones in your existing moles. Moles get darker, and new pigmented spots can appear, which is exactly the kind of change dermatologists watch for as an early melanoma signal. Darkening the whole field makes that signal harder to read. The Skin Cancer Foundation has issued a formal warning about it, and the medical literature carries case reports of melanoma alongside it, plus at least one of systemic toxicity severe enough to involve muscle breakdown and kidney strain. The causal link to melanoma is still just case reports, tangled with the fact that users often chase sun too. Unproven is not the same as safe. It's the reason to be careful, not a reason to relax.
What the split is actually about
It would be easy to read all this as "peptides are risky," and that's the wrong lesson. These two compounds are chemical cousins that pull the same lever. What separates them is not the family they belong to. It's the paperwork behind them: one went through controlled trials for a defined condition and came out the other side with a label and a monitoring plan, and the other never did. A tan from a peptide is still a real change to your melanocytes, driven by the same machinery the sun uses, minus the sun. Whether that change has been studied enough to trust depends entirely on which molecule you're talking about, and the two answers here could not be further apart.
This post is educational and general in nature. It is not medical advice. For guidance about your own health, talk to a qualified clinician.
Educational, general information — not medical advice. Talk to a clinician.